Osaic Holdings’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Hold |
67,989
| – | – | ﹤0.01% | 3076 |
|
|
2025
Q1 | $216K | Hold |
67,989
| – | – | ﹤0.01% | 3553 |
|
|
2024
Q4 | $364K | Buy |
67,989
+51,255
| +306% | +$274K | ﹤0.01% | 3081 |
|
|
2024
Q3 | $88.4K | Buy |
16,734
+16,200
| +3,034% | +$85.5K | ﹤0.01% | 4307 |
|
|
2024
Q2 | $971 | Sell |
534
-666
| -56% | -$1.21K | ﹤0.01% | 6639 |
|
|
2024
Q1 | $2.14K | Hold |
1,200
| – | – | ﹤0.01% | 6289 |
|
|
2023
Q4 | $2.11K | Sell |
1,200
-1,200
| -50% | -$2.11K | ﹤0.01% | 6400 |
|
|
2023
Q3 | $3.5K | Buy |
2,400
+1,300
| +118% | +$1.9K | ﹤0.01% | 6329 |
|
|
2023
Q2 | $2.52K | Hold |
1,100
| – | – | ﹤0.01% | 6478 |
|
|
2023
Q1 | $1K | Buy |
1,100
+1,000
| +1,000% | +$910 | ﹤0.01% | 6835 |
|
|
2022
Q4 | $0 | Sell |
100
-1,000
| -91% | – | ﹤0.01% | 7122 |
|
|
2022
Q3 | $1K | Hold |
1,100
| – | – | ﹤0.01% | 6869 |
|
|
2022
Q2 | $1K | Hold |
1,100
| – | – | ﹤0.01% | 6956 |
|
|
2022
Q1 | $2K | Hold |
1,100
| – | – | ﹤0.01% | 6719 |
|
|
2021
Q4 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 6733 |
|
|
2021
Q3 | $5K | Hold |
1,100
| – | – | ﹤0.01% | 6490 |
|
|
2021
Q2 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 6536 |
|
|
2021
Q1 | $3K | Buy |
1,100
+100
| +10% | +$273 | ﹤0.01% | 6290 |
|
|
2020
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 5765 |
|
|
2020
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 5581 |
|
|
2020
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 5578 |
|
|
2020
Q1 | $2K | Buy |
+1,000
| New | +$2K | ﹤0.01% | 5570 |
|